Françoise Meunier: Protecting Cancer Survivors from Financial Discrimination Throughout the EU
Jul 30, 2024, 13:26

Françoise Meunier: Protecting Cancer Survivors from Financial Discrimination Throughout the EU

“I am pleased to announce that my latest paper, ‘Protecting Cancer Survivors from Financial Discrimination Throughout the EU: A Cross-European Perspective,’ was published in the European Journal of Cancer. The paper provides an overview of the discussions and poignant testimonies shared during the High-Level Conference on Ending Financial Discrimination Against Cancer Survivors held on the 15th of February 2024, in Brussels.

The article sheds light on the profound impact of financial discrimination on cancer survivors’ lives, as well as on the moral and legal imperatives to address this form of discrimination.  It also stresses the crucial role of the cancer community’s advocacy to get legislation adopted and the need to garner strong and lasting political will and backing for legislation to effectively protect cancer survivors.

I conclude with recommendations for advancing the right to be forgotten through national and European legislation. The text insists on the need to find inspiration and replicate legal initiatives that have proven themselves over the years. The best practices from France and Belgium should serve as the basis for expanding the right to be forgotten throughout the EU – there is no need to reinvent the wheel!

You may access the article here.”

Source:

Françoise Meunier is a member of the science policy committee at the European Academy of Cancer Sciences. Prof. Meunier served as Director-General of the European organization for Research and Treatment of Cancer (1991-2015). 

Prof. Meunier was awarded the Belgian Laureate Prix Femmes d’Europe 2004-2005, conferred the title of Baroness by His Majesty, King Albert II of Belgium in 2007, received the Pezcoller Foundation award in 2009, became a Fellow of the European Academy of Cancer Sciences in 2011. She was appointed Chair of Accreditation Council of Oncology in Europe and Member of Alliance for Biomedical Research in Europe in 2015, and has been a member of the Belgian Royal Academy of Medicine since 2006.